ATS Foundation, ResMed Unveil Research Grant
ResMed will fund $100K for two-year research fellowship that will study sleep-disordered breathing and PAP therapy
- By David Kopf
- Apr 26, 2018
The ATS Foundation has launched the ATS Foundation/ResMed Research Fellowship in Sleep-disordered Breathing and PAP Therapy.
Sleep therapy equipment maker ResMed will fund $100,000, for two years starting December 2018 to December 2020. The grant application process will open April 26 and applications will be reviewed by the ATS Scientific Advisory Committee for their scientific merit, innovation, feasibility and relevance to sleep-disordered breathing and PAP therapy.
“Sleep apnea is a very common disease with significant morbidity and we need to learn so much more about how to diagnose and treat it most efficiently,” said Richard Schwab, MD, medical director of the Penn Centers for Sleep Disorders at the University of Pennsylvania Medical Center and chair of the ATS Scientific Advisory Committee. “Thus, we are very excited that the ATS and ResMed have partnered on a new two-year research fellowship to study sleep apnea and positive airway pressure. Such grants provide funding for the future leaders of the sleep field and will help patients who have sleep apnea.”
“This award can help shine a brighter light on sleep apnea – a public health crisis – and PAP therapy’s role in addressing it worldwide,” said Carlos M. Nunez, MD, ResMed Chief Medical Officer. “When 85 percent of people with sleep apnea still aren’t diagnosed, ResMed is proud to support any research effort to accelerate finding, testing and treating them so they can enjoy a full night’s rest, better overall health and a significant reduction of life-threatening risks.”
Interested applicants can learn more about the grant at www.thoracic.org/professionals/research/research-program-portfolio.
David Kopf is the Executive Editor of HME Business and DME Pharmacy magazine. Follow him on Twitter at @postacutenews.